Pregled bibliografske jedinice broj: 1184570
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index
The IPSS-R more accurately captures fatigue severity of newly diagnosed patients with myelodysplastic syndromes compared with the IPSS index // Leukemia, 34 (2020), 9; 2451-2459 doi:10.1038/s41375-020-0746-8 (međunarodna recenzija, članak, znanstveni)
CROSBI ID: 1184570 Za ispravke kontaktirajte CROSBI podršku putem web obrasca
Naslov
The IPSS-R more accurately captures fatigue
severity of newly diagnosed patients with
myelodysplastic syndromes compared with the IPSS
index
Autori
Efficace, Fabio ; Cottone, Francesco ; Oswald, Laura B. ; Cella, David ; Patriarca, Andrea ; Niscola, Pasquale ; Breccia, Massimo ; Platzbecker, Uwe ; Palumbo, Giuseppe A. ; Caocci, Giovanni ; Stauder, Reinhard ; Ricco, Alessandra ; Petranović, Duska ; Caers, Jo ; Luppi, Mario ; Fianchi, Luana ; Frairia, Chiara ; Capodanno, Isabella ; Follini, Elena ; Sarlo, Chiara ; Fazi, Paola ; Vignetti, Marco
Izvornik
Leukemia (0887-6924) 34
(2020), 9;
2451-2459
Vrsta, podvrsta i kategorija rada
Radovi u časopisima, članak, znanstveni
Ključne riječi
QUALITY-OF-LIFE ; WORLD-HEALTH-ORGANIZATION ; PROGNOSTIC SCORING SYSTEM ; FUNCTIONAL ASSESSMENT ; MYELOID NEOPLASMS ; RISK ; CLASSIFICATION ; ANEMIA ; SYMPTOMS ; SURVIVAL
Sažetak
We aimed to compare fatigue of newly diagnosed patients with myelodysplastic syndromes (MDS) with that of the general population (GP). We also investigated the ability of the IPSS and IPSS-R to capture severity of patient-reported fatigue at diagnostic workup. A sample of 927 newly diagnosed patients with MDS was consecutively enrolled in a large international observational study and all patients completed the FACIT-Fatigue questionnaire at baseline. Fatigue was compared with that of the GP (N = 1075) and a 3-point difference in mean scores was considered as clinically meaningful. Fatigue of MDS patients was on average 4.6 points below the mean of the GP (95% CI, -5.9 to -3.2, p < 0.001), reflecting clinically meaningful worse fatigue. Unlike the IPSS, the IPSS-R identified clearly distinct subgroups with regard to burden of fatigue. Mean scores differences compared with GP ranged from nonclinically relevant for very low risk (Δ = -1.8, 95% CI, -4.0 to 0.5, p = 0.119) to large clinically meaningful differences for very high-risk IPSS-R patients (Δ = -8.2, 95% CI, -10.3 to -6.2, p < 0.001). At diagnostic workup, fatigue of MDS is clinically meaningful worse than that reported by the GP. Compared with the IPSS classification, the IPSS-R provides a better stratification of patients with regard to fatigue severity.
Izvorni jezik
Engleski
Znanstvena područja
Kliničke medicinske znanosti
Citiraj ovu publikaciju:
Časopis indeksira:
- Current Contents Connect (CCC)
- Web of Science Core Collection (WoSCC)
- Science Citation Index Expanded (SCI-EXP)
- SCI-EXP, SSCI i/ili A&HCI
- Scopus
- MEDLINE